Feedback / Questions
Hemgenix (etranacogene dezaparvovec-drlb) - CSL Behring
https://www.newswire.ca/news-releases/csl-behring-signs-letter-of-intent-with-pan-canadian-pharmaceutical-alliance-pcpa-for-public-reimbursement-of-hemgenix-r-etranacogene-dezaparvovec-the-first-gene-therapy-for-hemophilia-b-850607490.html
Oct 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next